TOPOTECAN HYDROCHLORIDE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2014-05-08
- Label type
- Indexing - Product Concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:13:58
Label at a glance#
ProductTOPOTECAN HYDROCHLORIDE
Active ingredientTOPOTECAN HYDROCHLORIDE
Products#
Every source-derived product name is available through these pages.
- TOPOTECAN HYDROCHLORIDE
- TOPOTECAN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TOPOTECAN HYDROCHLORIDE | 956S425ZCY | ACTIM |
| TOPOTECAN HYDROCHLORIDE | 956S425ZCY | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topotecan Hydrochloride | TOPOTECAN HYDROCHLORIDE | Fresenius Kabi USA, LLC | b6019088-cd94-43b4-b5ce-ba20b6b8021e | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | Topotecan Hydrochloride TOPOTECAN HYDROCHLORIDE |
| topotecan hydrochloride | TOPOTECAN HYDROCHLORIDE | Accord Healthcare, Inc. | 729b2b22-1344-44f3-b614-14f6ec3c263e | 2024-10-04 | Boxed warning, Warnings, Adverse reactions | topotecan hydrochloride TOPOTECAN HYDROCHLORIDE |
| Topotecan hydrochloride | TOPOTECAN HYDROCHLORIDE | Actavis Pharma, Inc. | 996430c0-ee26-4ed9-82b8-a8b645becba6 | 2022-08-31 | Boxed warning, Warnings, Adverse reactions | Topotecan hydrochloride TOPOTECAN HYDROCHLORIDE |
| HYCAMTIN | TOPOTECAN HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | eeee060c-a9ec-423e-a374-8484009f8524 | 2022-07-07 | Boxed warning, Warnings, Adverse reactions | TOPOTECAN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.